Preclinical Development of a Novel Therapeutic to Rejuvenate Aging Muscle Stem Cells and Enhance Muscle Strength and Function Post Hip Fracture

Project: Research project

Project Details

Description

(Re-established from CON30675 when Volpi left UTMB)
StatusActive
Effective start/end date9/30/228/31/24

Funding

  • Ridgeline Therapeutics, LLC: $11,501.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.